Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215000 · ClinicalTrials.gov registry record · Phase 4
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
A Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy, sponsored by Morehouse School of Medicine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07215000 is a Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy that is actively recruiting participants, run by Morehouse School of Medicine. The registered enrollment target is 300 participants, below the 5,867-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07215000, a Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy, is actively recruiting participants, sponsored by Morehouse School of Medicine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one of the two preparation methods in a 2:1 ratio prior to their scheduled colonoscopy appointments. Surveys will be conducted both before and after the procedures. This project will be conducted over a 12-month period and seeks to compare patient experience of both preparation methods in an outpatient setting. The study will evaluate the rate of preparation completion, patient satisfaction, tolerance of the solutions, and the endoscopic adequacy of each method. Eligible participants are patients aged 18 or older with upcoming colonoscopy appointments who can provide informed consent in English or Spanish. There is no health risks associated with this study, as both bowel preparation methods are FDA-approved and commonly used in clinical practice.
Conditions Studied
Interventions
- DRUG Golytely
- DRUG Sulfave
- DRUG Sutab
Study Locations (1)
Georgia
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07215000
The ClinicalTrials.gov registry entry for NCT07215000 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,867-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (95% lower). The listed sponsor is Morehouse School of Medicine, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 3 interventions - of which Golytely is the first listed.
NCT07215000 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07215000 about?
NCT07215000 is a clinical study titled "Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial". The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one o...
What is the current status of trial NCT07215000?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2025-10-01. Estimated completion is 2027-06.
What conditions does trial NCT07215000 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening, Bowel Cleansing for Colonoscopy.
What interventions are being tested in trial NCT07215000?
The interventions under investigation include: Golytely (DRUG), Sulfave (DRUG), Sutab (DRUG).
Who is sponsoring clinical trial NCT07215000?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215000 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
-
CRC Screening in Unscreened Individuals 45-54
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.